(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 09/30/2024 | 96,501,526 | Total gross of voting rights: 96,501,526 |
| Total net* of voting rights: 96,199,467 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$4.53 |
| Daily Change: | 0.47 11.58 |
| Daily Volume: | 292,704 |
| Market Cap: | US$92.960M |
January 08, 2025 December 11, 2024 November 06, 2024 October 22, 2024 September 23, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
